Table 3.
Randomized studies of neoadjuvant chemotherapy versus mutilating surgery
supraglottic larynx (including epilarynx), †glottic larynx; ‡subglottic larynx (excluding the epilarynx), §epilarynx; ∥larynx unspecified (transglottic?), ¶surgery arm versus chemotherapy arm, NP: not specified, NS: not significant, LP: larynx preserved. **At 3 years.††At 2 years. ‡‡At 5 year.